Received Jul 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
Extra dose suggested by Physician not yet given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intercepted medication error in a elderly male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received second dose on 30 Aug 2022 with lot 5H29X and FA95N) and Shingrix (first one on July 5th, 2022). On an unknown date, the patient did not receive the 3rd dose of Shingrix. On an unknown date, an unknown time after not receiving Shingrix, the patient experienced intercepted medication error (Verbatim: Extra dose suggested by Physician not yet given). The outcome of the intercepted medication error was not applicable. Additional Information: GSK Receipt Date: 26-JUN-2025 Pharmacist mentioned that an immunocompetent patient already got 2 doses of Shingrix in another facility, first one on July 5th, 2022, and the second one on August 30th 2022. Physician of the patient noticed that the doses are too close together and suggested to give a third dose but caller did not administer it yet which led to Intercepted medication error, since they wanted to confirm with Glaxo Smith Kline what recommendations they have.